Home Compare ASM.AS vs NOVO-B.CO
Stock Comparison · Comparison

ASM International vs Novo Nordisk A/S: Which Stock Looks Stronger in 2026?

Novo Nordisk A/S holds the cleaner structural position, with the lead spread across growth and valuation. ASM International does not offset that deficit through any equally strong structural edge elsewhere. In the market, ASM International carries the stronger setup — intact trend against Novo Nordisk A/S's broken trend. That leaves a split case: the structural lead stays with Novo Nordisk A/S, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the STOXX 600 universe, making them directly comparable.

Updated 2026-07-05

The clearest separation starts in growth, but valuation adds another real layer to the result. Novo Nordisk A/S leads by 47 points on the overall comparison score.

Trajectory Similarity
0.65
Moderately similar
Peer-set rank: #14
within ASM International NV's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The strongest overlap appears in capital structure and margin consistency.

Similarity drivers
capital structuremargin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
ASM.AS
ASM International NV
34
Peer-Score
Signal qualitylow
Peer basis: STOXX 600
vs
NOVO-B.CO
Novo Nordisk A/S
81
Peer-Score
Signal qualityMedium
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: ASM.AS vs NOVO-B.CO Profitability 53 92 Stability 30 44 Valuation 27 86 Growth 21 94 ASM.AS NOVO-B.CO
Gap Ranking
#1 Growth +73
#2 Valuation +59
#3 Profitability +39
#4 Stability +14
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ASM.AS and NOVO-B.CO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ASM.ASNOVO-B.CO Relative valuation Structural strength

Novo Nordisk A/S looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where ASM.AS and NOVO-B.CO each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY ASM.AS Elevated · above norm 0th 50th 100th 74 pct gap NOVO-B.CO Lower · below norm 0th 50th 100th 99th 25th
Today NOVO-B.CO sits in the lower portion of its own 5-year history (25th percentile), while ASM.AS sits higher in its own history (99th). Within each stock's own 5-year context, NOVO-B.CO is at a historically more favourable entry position than ASM.AS. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Growth
On growth, Novo Nordisk A/S ranks near the top of the group; ASM International NV sits in the weaker half.
Valuation
On valuation, the gap still runs the same way: Novo Nordisk A/S sits near the top of the group, while ASM International NV remains in the weaker half.
Growth — Dominant Gap
ASM.AS
21
NOVO-B.CO
94
Gap+73in favour of NOVO-B.CO

Revenue growth reinforces the category-level growth lead.

What keeps the gap from being one-sided

On the market side, ASM International carries the stronger trend while Novo Nordisk A/S's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

The lead is built on both growth and valuation, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the ASM.AS vs NOVO-B.CO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-valuation comparisons

Explore how ASM.AS and NOVO-B.CO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.